⌘K

Login Start Free

Home/Filings/4/0001628280-25-002388

4//SEC Filing

Hudson Frederick M. 4

Accession 0001628280-25-002388

CIK 0001356576other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:33 PM ET

Size

6.6 KB

Accession

0001628280-25-002388

Insider Transaction Report

Form 4

Period: 2025-01-22

SUPERNUS PHARMACEUTICALS, INC.SUPN

Hudson Frederick M.

Director

Transactions

Exercise/Conversion
Director Stock Option (Right to Buy)
2025-01-22−20,000→ 0 total
Exercise: $9.13From: 2016-03-03Exp: 2025-03-03→ Common Stock (20,000 underlying)
Exercise/Conversion
Common Stock
2025-01-22$9.13/sh+20,000$182,600→ 48,395 total

Documents

1 file

4
wk-form4_1737668026.xmlPrimary
FORM 4

Issuer

SUPERNUS PHARMACEUTICALS, INC.

CIK 0001356576

Entity typeother

Related Parties

1

filerCIK 0001438462

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 4:33 PM ET
Size: 6.6 KB

View on SEC.gov